ARTICLE | Company News
SmithKline to develop Novavax HEV technology
September 14, 2000 7:00 AM UTC
NOX said the National Institute for Allergy and Infectious Diseases, its partner in developing recombinant hepatitis E virus clones and antigen production technology, has licensed the technology to SB...